Cresco Labs Inc. (CRLBF) Long-Term Deferred Tax (2019 - 2026)

Cresco Labs (CRLBF) has reported Long-Term Deferred Tax for 8 consecutive years, with $28.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Long-Term Deferred Tax rose 119.9% year-over-year to $28.1 million; the trailing twelve-month figure through Jun 2026 stood at $28.1 million (up 119.9% YoY), and the FY2025 full-year result was $13.5 million, up 2.85% from the prior year.
• Long-Term Deferred Tax rose to $28.1 million in Q2 2026 per CRLBF's latest filing, from $13.6 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $28.1 million in Q2 2026 and bottomed at $26000.0 in Q4 2022.
• Historically, Long-Term Deferred Tax has averaged $11.6 million across 5 years, with a median of $12.6 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Long-Term Deferred Tax plunged 99.6% in 2022, then jumped 44311.54% in 2023.
• Over 5 years, Long-Term Deferred Tax stood at $26000.0 in 2022, then surged by 44311.54% to $11.5 million in 2023, then advanced by 13.68% to $13.1 million in 2024, then advanced by 2.85% to $13.5 million in 2025, then soared by 107.99% to $28.1 million in 2026.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $28.1 million, $13.6 million, and $13.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.